Mark A. Micale, Ph.D., F.A.C.M.G.

Director, Center for DNA Diagnostics       Clinical Associate Professor of Pathology
William Beaumont Hospital                              and Pediatrics
Royal Oak, Michigan                                       University of Toledo Health Sciences Campus

Education and Training:

Ph.D., Wayne State University
Clinical Fellowships in Cytogenetics and Molecular Genetics: Case Western Reserve University Center for Human Genetics

Board Certification:

  • American Board of Medical Genetics: Clinical Cytogenetics
  • Clinical Molecular Genetics

Primary Clinical and Educational Responsibilities:

  • Director, Center for DNA Diagnostics
  • 1st Year Curriculum: Medical Genetics Lectures
  • 2nd Year Curriculum: Cancer Genetics Lectures
  • Resident Education; Medical Genetics and Molecular Pathology

Recent Publications:

Micale MA, Schran D, Emch S, Kurczynski TW, Rahman N, Van Dyke DL. Mosaic variegated aneuploidy without microcephaly: implications for cytogenetic diagnosis. Amer J Med Genet Part A 143:1890-3, 2007

Van Dyke DL, Ebrahim SA, Al Saadi AA, Powell SA, Zenger-Hain JL, Micale MA.,Wiktor AE, Zou YS. The impact of maternal serum screening programs for Down syndrome in southeast Michigan, 1988-2003. Prenatal Diagnosis 27:583-4, 2007
Last Updated: 6/9/16